Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kenneth, Biason"'
Autor:
Esther Molnar, Kenneth Biason, Yi Guo, Deepali Dixit, Michael J. Satlin, Emily L. Heil, Abdulrahman Elabor, Kimberly C. Claeys, Erin K McCreary, Saira B. Chaudhry, Jon Hiles, Dorothy McCoy, Nidhi Saraiya, Jason C. Gallagher, Claudine El-Beyrouty, Madeline A King, Lynette Richards, Christopher M. Bland, Daohai Yu, Jin S Suh, Nikunj Vyas, Bruce M Jones, Xiaoning Lu, Nicole Harrington
Publikováno v:
Open Forum Infectious Diseases. 5
Background Multidrug-resistant Pseudomonas aeruginosa infections remain common in hospitals worldwide. We investigated the outcomes associated with the use of ceftolozane-tazobactam for the treatment of these infections. Methods Data were collected r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3731563f672f2cc1ffbbe4808180db38
https://doi.org/10.1093/ofid/ofy280
https://doi.org/10.1093/ofid/ofy280
Autor:
Jason C, Gallagher, Michael J, Satlin, Abdulrahman, Elabor, Nidhi, Saraiya, Erin K, McCreary, Esther, Molnar, Claudine, El-Beyrouty, Bruce M, Jones, Deepali, Dixit, Emily L, Heil, Kimberly C, Claeys, Jon, Hiles, Nikunj M, Vyas, Christopher M, Bland, Jin, Suh, Kenneth, Biason, Dorothy, McCoy, Madeline A, King, Lynette, Richards, Nicole, Harrington, Yi, Guo, Saira, Chaudhry, Xiaoning, Lu, Daohai, Yu
Publikováno v:
Open Forum Infectious Diseases
Background Multidrug-resistant Pseudomonas aeruginosa infections remain common in hospitals worldwide. We investigated the outcomes associated with the use of ceftolozane-tazobactam for the treatment of these infections. Methods Data were collected r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7b88cb0b979b2704dccc37f5138a405
https://pubmed.ncbi.nlm.nih.gov/30488041
https://pubmed.ncbi.nlm.nih.gov/30488041
Autor:
Dorothy McCoy, Jon Hiles, Madeline King, Vanthida Huang, Nicole Harrington, Tiffany E. Bias, Lynette Richards, Safia Kuriakose, Julianne Gardner, Claudine El-Beyrouty, Jason C. Gallagher, Kenneth Biason, Emily L. Heil
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
Ceftazidime-avibactam is a novel cephalosporin–beta-lactamase inhibitor combination that is active against many carbapenem-resistant Enterobacteriaceae (CRE). We describe a retrospective chart review for 60 patients who received ceftazidime-avibact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80881cd69bce3d85163e32cead3e14a4
https://doi.org/10.1128/aac.00449-17
https://doi.org/10.1128/aac.00449-17